RE:What NextIt is pretty hard to sell a Private Placement at $.10 mind you with warrants when you can buy shares on the open market at $.09. I was a bit surprised that the update didn't spark a little interest in Replicel.
Unfortunatley there has been a bit to much "crying wolf" with this company for people to believe the hype.
With this Shiseido Arbitration elephant in the room hanging over this company you would have to rate this high risk at best.
The update was encouraging but when it boils down it is still a long ways from generating revenue and that is what is killing the share price at the moment.
For those of us that have been here for years with averages much higher than $.09 all we can do is hang in there.